カテゴリー： Market Monitor Global, 世界, 医療/バイオ

バセドウ病治療の世界市場見通し2023年-2029年

◆英語タイトル：Graves Disease Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5597）◆商品コード：MMG23JU5597
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Graves Disease Treatment Market 調査レポートは次の情報を含め、グローバルにおけるのバセドウ病治療市場規模と予測を収録しています。・世界のバセドウ病治療市場：売上、2018年-2023年、2024年-2029年
・世界のバセドウ病治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバセドウ病治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗甲状腺薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

バセドウ病治療のグローバル主要企業は、Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、バセドウ病治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のバセドウ病治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：タイプ別市場シェア、2022年
・抗甲状腺薬、放射性ヨウ素療法

世界のバセドウ病治療市場：用途別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：用途別市場シェア、2022年
・病院薬局、小売薬局

世界のバセドウ病治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるバセドウ病治療のグローバル売上、2018年-2023年
・主要企業におけるバセドウ病治療のグローバル売上シェア、2022年
・主要企業におけるバセドウ病治療のグローバル販売量、2018年-2023年
・主要企業におけるバセドウ病治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Inc

*************************************************************

・調査・分析レポートの概要
バセドウ病治療市場の定義
市場セグメント
世界のバセドウ病治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバセドウ病治療市場規模
世界のバセドウ病治療市場規模：2022年 VS 2029年
世界のバセドウ病治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバセドウ病治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバセドウ病治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗甲状腺薬、放射性ヨウ素療法
バセドウ病治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局
バセドウ病治療の用途別グローバル売上・予測

・地域別市場分析
地域別バセドウ病治療市場規模 2022年と2029年
地域別バセドウ病治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Inc
...

Graves’ disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves’ disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves’ disease can be wide ranging.
This report aims to provide a comprehensive presentation of the global market for Graves Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Graves Disease Treatment. This report contains market size and forecasts of Graves Disease Treatment in global, including the following market information:
Global Graves Disease Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Graves Disease Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Graves Disease Treatment companies in 2022 (%)
The global Graves Disease Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-Thyroid Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Type, 2022 (%)
Anti-Thyroid Medication
Radioactive Iodine Therapy
Global Graves Disease Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacies
Retail Pharmacies
Global Graves Disease Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Graves Disease Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Graves Disease Treatment revenues share in global market, 2022 (%)
Key companies Graves Disease Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Graves Disease Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Graves Disease Treatment, market overview.
Chapter 2: Global Graves Disease Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Graves Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Graves Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Graves Disease Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Graves Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Graves Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Graves Disease Treatment Overall Market Size
2.1 Global Graves Disease Treatment Market Size: 2022 VS 2029
2.2 Global Graves Disease Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Graves Disease Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Graves Disease Treatment Players in Global Market
3.2 Top Global Graves Disease Treatment Companies Ranked by Revenue
3.3 Global Graves Disease Treatment Revenue by Companies
3.4 Global Graves Disease Treatment Sales by Companies
3.5 Global Graves Disease Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Graves Disease Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Graves Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Graves Disease Treatment Players in Global Market
3.8.1 List of Global Tier 1 Graves Disease Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Graves Disease Treatment Market Size Markets, 2022 & 2029
4.1.2 Anti-Thyroid Medication
4.1.3 Radioactive Iodine Therapy
4.2 By Type – Global Graves Disease Treatment Revenue & Forecasts
4.2.1 By Type – Global Graves Disease Treatment Revenue, 2018-2023
4.2.2 By Type – Global Graves Disease Treatment Revenue, 2024-2029
4.2.3 By Type – Global Graves Disease Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Graves Disease Treatment Sales & Forecasts
4.3.1 By Type – Global Graves Disease Treatment Sales, 2018-2023
4.3.2 By Type – Global Graves Disease Treatment Sales, 2024-2029
4.3.3 By Type – Global Graves Disease Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Graves Disease Treatment Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application – Global Graves Disease Treatment Revenue & Forecasts
5.2.1 By Application – Global Graves Disease Treatment Revenue, 2018-2023
5.2.2 By Application – Global Graves Disease Treatment Revenue, 2024-2029
5.2.3 By Application – Global Graves Disease Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Graves Disease Treatment Sales & Forecasts
5.3.1 By Application – Global Graves Disease Treatment Sales, 2018-2023
5.3.2 By Application – Global Graves Disease Treatment Sales, 2024-2029
5.3.3 By Application – Global Graves Disease Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Graves Disease Treatment Market Size, 2022 & 2029
6.2 By Region – Global Graves Disease Treatment Revenue & Forecasts
6.2.1 By Region – Global Graves Disease Treatment Revenue, 2018-2023
6.2.2 By Region – Global Graves Disease Treatment Revenue, 2024-2029
6.2.3 By Region – Global Graves Disease Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Graves Disease Treatment Sales & Forecasts
6.3.1 By Region – Global Graves Disease Treatment Sales, 2018-2023
6.3.2 By Region – Global Graves Disease Treatment Sales, 2024-2029
6.3.3 By Region – Global Graves Disease Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Graves Disease Treatment Revenue, 2018-2029
6.4.2 By Country – North America Graves Disease Treatment Sales, 2018-2029
6.4.3 US Graves Disease Treatment Market Size, 2018-2029
6.4.4 Canada Graves Disease Treatment Market Size, 2018-2029
6.4.5 Mexico Graves Disease Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Graves Disease Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Graves Disease Treatment Sales, 2018-2029
6.5.3 Germany Graves Disease Treatment Market Size, 2018-2029
6.5.4 France Graves Disease Treatment Market Size, 2018-2029
6.5.5 U.K. Graves Disease Treatment Market Size, 2018-2029
6.5.6 Italy Graves Disease Treatment Market Size, 2018-2029
6.5.7 Russia Graves Disease Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Graves Disease Treatment Market Size, 2018-2029
6.5.9 Benelux Graves Disease Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Graves Disease Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Graves Disease Treatment Sales, 2018-2029
6.6.3 China Graves Disease Treatment Market Size, 2018-2029
6.6.4 Japan Graves Disease Treatment Market Size, 2018-2029
6.6.5 South Korea Graves Disease Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Graves Disease Treatment Market Size, 2018-2029
6.6.7 India Graves Disease Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Graves Disease Treatment Revenue, 2018-2029
6.7.2 By Country – South America Graves Disease Treatment Sales, 2018-2029
6.7.3 Brazil Graves Disease Treatment Market Size, 2018-2029
6.7.4 Argentina Graves Disease Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Graves Disease Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Graves Disease Treatment Sales, 2018-2029
6.8.3 Turkey Graves Disease Treatment Market Size, 2018-2029
6.8.4 Israel Graves Disease Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Graves Disease Treatment Market Size, 2018-2029
6.8.6 UAE Graves Disease Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Graves Disease Treatment Major Product Offerings
7.1.4 Abbott Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Graves Disease Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline plc Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Graves Disease Treatment Major Product Offerings
7.3.4 Merck & Co Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer, Inc
7.4.1 Pfizer, Inc Company Summary
7.4.2 Pfizer, Inc Business Overview
7.4.3 Pfizer, Inc Graves Disease Treatment Major Product Offerings
7.4.4 Pfizer, Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer, Inc Key News & Latest Developments
7.5 RLC LABS
7.5.1 RLC LABS Company Summary
7.5.2 RLC LABS Business Overview
7.5.3 RLC LABS Graves Disease Treatment Major Product Offerings
7.5.4 RLC LABS Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.5.5 RLC LABS Key News & Latest Developments
7.6 AbbVie, Inc
7.6.1 AbbVie, Inc Company Summary
7.6.2 AbbVie, Inc Business Overview
7.6.3 AbbVie, Inc Graves Disease Treatment Major Product Offerings
7.6.4 AbbVie, Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie, Inc Key News & Latest Developments
7.7 Mylan N.V
7.7.1 Mylan N.V Company Summary
7.7.2 Mylan N.V Business Overview
7.7.3 Mylan N.V Graves Disease Treatment Major Product Offerings
7.7.4 Mylan N.V Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Mylan N.V Key News & Latest Developments
7.8 Allergan, plc
7.8.1 Allergan, plc Company Summary
7.8.2 Allergan, plc Business Overview
7.8.3 Allergan, plc Graves Disease Treatment Major Product Offerings
7.8.4 Allergan, plc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.8.5 Allergan, plc Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Graves Disease Treatment Major Product Offerings
7.9.4 Novartis AG Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Apitope
7.10.1 Apitope Company Summary
7.10.2 Apitope Business Overview
7.10.3 Apitope Graves Disease Treatment Major Product Offerings
7.10.4 Apitope Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.10.5 Apitope Key News & Latest Developments
7.11 Amgen INC.
7.11.1 Amgen INC. Company Summary
7.11.2 Amgen INC. Graves Disease Treatment Business Overview
7.11.3 Amgen INC. Graves Disease Treatment Major Product Offerings
7.11.4 Amgen INC. Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.11.5 Amgen INC. Key News & Latest Developments
7.12 Sun Pharmaceuticals Industries LTD
7.12.1 Sun Pharmaceuticals Industries LTD Company Summary
7.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Business Overview
7.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Major Product Offerings
7.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Sun Pharmaceuticals Industries LTD Key News & Latest Developments
7.13 Immunovant Inc
7.13.1 Immunovant Inc Company Summary
7.13.2 Immunovant Inc Graves Disease Treatment Business Overview
7.13.3 Immunovant Inc Graves Disease Treatment Major Product Offerings
7.13.4 Immunovant Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.13.5 Immunovant Inc Key News & Latest Developments
8 Global Graves Disease Treatment Production Capacity, Analysis
8.1 Global Graves Disease Treatment Production Capacity, 2018-2029
8.2 Graves Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Graves Disease Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Graves Disease Treatment Supply Chain Analysis
10.1 Graves Disease Treatment Industry Value Chain
10.2 Graves Disease Treatment Upstream Market
10.3 Graves Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Graves Disease Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Graves Disease Treatment in Global Market
Table 2. Top Graves Disease Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Graves Disease Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Graves Disease Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Graves Disease Treatment Sales by Companies, (K Units), 2018-2023
Table 6. Global Graves Disease Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Graves Disease Treatment Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Graves Disease Treatment Product Type
Table 9. List of Global Tier 1 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Graves Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Graves Disease Treatment Sales (K Units), 2018-2023
Table 15. By Type - Global Graves Disease Treatment Sales (K Units), 2024-2029
Table 16. By Application – Global Graves Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Graves Disease Treatment Sales (K Units), 2018-2023
Table 20. By Application - Global Graves Disease Treatment Sales (K Units), 2024-2029
Table 21. By Region – Global Graves Disease Treatment Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Graves Disease Treatment Sales (K Units), 2018-2023
Table 25. By Region - Global Graves Disease Treatment Sales (K Units), 2024-2029
Table 26. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Graves Disease Treatment Sales, (K Units), 2018-2023
Table 29. By Country - North America Graves Disease Treatment Sales, (K Units), 2024-2029
Table 30. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Graves Disease Treatment Sales, (K Units), 2018-2023
Table 33. By Country - Europe Graves Disease Treatment Sales, (K Units), 2024-2029
Table 34. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Graves Disease Treatment Sales, (K Units), 2018-2023
Table 37. By Region - Asia Graves Disease Treatment Sales, (K Units), 2024-2029
Table 38. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Graves Disease Treatment Sales, (K Units), 2018-2023
Table 41. By Country - South America Graves Disease Treatment Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2024-2029
Table 46. Abbott Company Summary
Table 47. Abbott Graves Disease Treatment Product Offerings
Table 48. Abbott Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. GlaxoSmithKline plc Company Summary
Table 51. GlaxoSmithKline plc Graves Disease Treatment Product Offerings
Table 52. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GlaxoSmithKline plc Key News & Latest Developments
Table 54. Merck & Co Company Summary
Table 55. Merck & Co Graves Disease Treatment Product Offerings
Table 56. Merck & Co Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck & Co Key News & Latest Developments
Table 58. Pfizer, Inc Company Summary
Table 59. Pfizer, Inc Graves Disease Treatment Product Offerings
Table 60. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer, Inc Key News & Latest Developments
Table 62. RLC LABS Company Summary
Table 63. RLC LABS Graves Disease Treatment Product Offerings
Table 64. RLC LABS Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. RLC LABS Key News & Latest Developments
Table 66. AbbVie, Inc Company Summary
Table 67. AbbVie, Inc Graves Disease Treatment Product Offerings
Table 68. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AbbVie, Inc Key News & Latest Developments
Table 70. Mylan N.V Company Summary
Table 71. Mylan N.V Graves Disease Treatment Product Offerings
Table 72. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Mylan N.V Key News & Latest Developments
Table 74. Allergan, plc Company Summary
Table 75. Allergan, plc Graves Disease Treatment Product Offerings
Table 76. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Allergan, plc Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Graves Disease Treatment Product Offerings
Table 80. Novartis AG Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. Apitope Company Summary
Table 83. Apitope Graves Disease Treatment Product Offerings
Table 84. Apitope Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Apitope Key News & Latest Developments
Table 86. Amgen INC. Company Summary
Table 87. Amgen INC. Graves Disease Treatment Product Offerings
Table 88. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Amgen INC. Key News & Latest Developments
Table 90. Sun Pharmaceuticals Industries LTD Company Summary
Table 91. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offerings
Table 92. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sun Pharmaceuticals Industries LTD Key News & Latest Developments
Table 94. Immunovant Inc Company Summary
Table 95. Immunovant Inc Graves Disease Treatment Product Offerings
Table 96. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Immunovant Inc Key News & Latest Developments
Table 98. Graves Disease Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Graves Disease Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Graves Disease Treatment Production by Region, 2018-2023 (K Units)
Table 101. Global Graves Disease Treatment Production by Region, 2024-2029 (K Units)
Table 102. Graves Disease Treatment Market Opportunities & Trends in Global Market
Table 103. Graves Disease Treatment Market Drivers in Global Market
Table 104. Graves Disease Treatment Market Restraints in Global Market
Table 105. Graves Disease Treatment Raw Materials
Table 106. Graves Disease Treatment Raw Materials Suppliers in Global Market
Table 107. Typical Graves Disease Treatment Downstream
Table 108. Graves Disease Treatment Downstream Clients in Global Market
Table 109. Graves Disease Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Graves Disease Treatment Segment by Type in 2022
Figure 2. Graves Disease Treatment Segment by Application in 2022
Figure 3. Global Graves Disease Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Graves Disease Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Graves Disease Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. Graves Disease Treatment Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Graves Disease Treatment Revenue in 2022
Figure 9. By Type - Global Graves Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 11. By Type - Global Graves Disease Treatment Sales Market Share, 2018-2029
Figure 12. By Type - Global Graves Disease Treatment Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Graves Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 15. By Application - Global Graves Disease Treatment Sales Market Share, 2018-2029
Figure 16. By Application - Global Graves Disease Treatment Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Graves Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Graves Disease Treatment Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 20. By Region - Global Graves Disease Treatment Sales Market Share, 2018-2029
Figure 21. By Country - North America Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 22. By Country - North America Graves Disease Treatment Sales Market Share, 2018-2029
Figure 23. US Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Graves Disease Treatment Sales Market Share, 2018-2029
Figure 28. Germany Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. France Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Graves Disease Treatment Sales Market Share, 2018-2029
Figure 37. China Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. India Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 43. By Country - South America Graves Disease Treatment Sales Market Share, 2018-2029
Figure 44. Brazil Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Graves Disease Treatment Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Graves Disease Treatment Sales Market Share, 2018-2029
Figure 48. Turkey Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Graves Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 52. Global Graves Disease Treatment Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Graves Disease Treatment by Region, 2022 VS 2029
Figure 54. Graves Disease Treatment Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ バセドウ病治療の世界市場見通し2023年-2029年(Graves Disease Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 呼吸器疾患治療の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆